Oncologic imaging: Kidney and ureter

Bruce L. McClennan, Dennis M. Balfe

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Malignant cancers of the kidney and ureter account for only 2-3% of all neoplasms in man. However, early diagnosis and treatment can have a profound effect on patient prognosis and survival. This article seeks to amalgamate a large body of information related to the pathology of primary renal tumors and metastatic disease with current imaging strategies to assist the clinician and enhance his understanding of the wide variety of modern imaging techniques available. Current tumor staging classifications are presented and the various imaging strategies are keyed to detection, definition and treatment options for tumors of the renal parenchyma and ureter. The strengths and limitations of all available imaging modalities are reviewed. An optimal approach to the imaging work up is developed with regard to availability, evolving technology and most importantly, cost efficacy. The controversies and conflicts in imaging and treatment options are explored while constructing a step by step approach that will be both flexible and utilitarian for the clinician faced with daily oncologic management choices.

Original languageEnglish
Pages (from-to)1683-1704
Number of pages22
JournalInternational journal of radiation oncology, biology, physics
Issue number11
StatePublished - Nov 1983


  • CT scanning
  • Diagnostic Imaging
  • Kidney
  • Ultrasound
  • Ureter


Dive into the research topics of 'Oncologic imaging: Kidney and ureter'. Together they form a unique fingerprint.

Cite this